Chief Executive Officer
Dr. Murphy has more than 15 years of experience in drug development and evaluation. Most recently he served as the Chief Medical Officer of Eiger Biosciences, and prior to that held the same position at Valeant Pharmaceuticals International (VRX). Dr. Murphy has also served as a Medical Director at InterMune, Inc. (ITMN), and Hoffmann-LaRoche, as well as Assistant Professor of Medicine at New York Medical College and Director of the Clinical Strategies Programs at St. Vincent’s Hospital in New York City. Board-certified in internal medicine, Dr. Murphy earned his MD, MPH (general public health), and MS (pharmacology) degrees from New York Medical College and is a graduate of the Harvard School of Public Health (MPH in Health Policy and Management). He earned his MBA at the Columbia University Graduate School of Business.